Summit Therapeutics (SMMT) Short-term Investments (2022 - 2025)
Historic Short-term Investments for Summit Therapeutics (SMMT) over the last 4 years, with Q3 2025 value amounting to $321000.0.
- Summit Therapeutics' Short-term Investments fell 61.92% to $321000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $321000.0, marking a year-over-year decrease of 61.92%. This contributed to the annual value of $307.5 million for FY2024, which is 16780.62% up from last year.
- According to the latest figures from Q3 2025, Summit Therapeutics' Short-term Investments is $321000.0, which was down 61.92% from $319000.0 recorded in Q2 2025.
- Over the past 5 years, Summit Therapeutics' Short-term Investments peaked at $307.5 million during Q4 2024, and registered a low of $317000.0 during Q1 2024.
- Moreover, its 4-year median value for Short-term Investments was $132.3 million (2023), whereas its average is $116.1 million.
- In the last 5 years, Summit Therapeutics' Short-term Investments plummeted by 9981.56% in 2024 and then soared by 4715205.05% in 2025.
- Summit Therapeutics' Short-term Investments (Quarter) stood at $300.0 million in 2022, then crashed by 61.73% to $114.8 million in 2023, then surged by 167.81% to $307.5 million in 2024, then plummeted by 99.9% to $321000.0 in 2025.
- Its last three reported values are $321000.0 in Q3 2025, $319000.0 for Q2 2025, and $149.8 million during Q1 2025.